Vivek Ramaswamy Biography
Vivek Ramaswamy is an American entrepreneur who announced his candidacy for the Republican Party’s 2024 presidential nomination in 2023. Ramaswamy suspended his campaign in January 2024 after endorsing Trump and placing fourth in the Iowa caucuses.Elon Musk and Ramaswamy were named the Department of Government Efficiency’s leaders by President-elect Donald Trump in November 2024.
Ramaswamy Age
Vivek is 39 years old as of 9 August 2024. He was born on 9 August 1985 in Cincinnati, Ohio, United States.
Ramaswamy Parents and Family
On August 9, 1985, Ramaswamy was born in Cincinnati, Ohio, to parents who were Indian Hindu immigrants. His parents are Keralan Brahmins who speak Tamil.His mother, Geetha Ramaswamy, a graduate of the Mysore Medical College & Research Institute, was a geriatric psychiatrist, and his father, V. Ganapathy Ramaswamy, a graduate of the National Institute of Technology Calicut, was an engineer and patent lawyer for General Electric. His parents were from Kerala’s Palakkad district, where they owned an ancestral home in Vadakkencherry, a typical agraharam.
Ramaswamy Wife
Apoorva Tewari Ramaswamy, Ramaswamy’s wife, is a laryngologist and surgeon. They met at Yale when she was a medical student and he was a law student. They have two sons and were married in 2015. Shankar, Ramaswamy’s younger brother, was a coworker at Axovant before helping to start the biopharmaceutical business Kriya Therapeutics.
Ramaswamy Height
Vivek stands at a height of f 6 feet 3 inches.
Ramaswamy’s House
In 2016, he resided in Manhattan. He claimed to only possess a home in Columbus, Ohio, in Franklin County, in 2023, however he did own a home in Butler County, Ohio, in 2021. According to Ramaswamy’s 2023 Politico article, he resides in a $2 million mansion in the Upper Arlington area of Columbus.
Ramaswamy Religion
Ramaswamy believes that “new secular religions like COVID-ism, climate-ism, and gender ideology” are to blame for the current national identity crisis in the United States. Environmental, social, and corporate governance (ESG) initiatives are also criticized by him. Forbes assessed Ramaswamy’s net worth at around $960 million in January 2024; his money is derived from finance and biotech ventures.
Ramaswamy Career
Ramaswamy established Roivant Sciences, a biotechnology company, in 2014 with the goal of acquiring patents for undeveloped medications from bigger pharmaceutical firms. The business acquired about $100 million in startup funding from a variety of investors after being formed in Bermuda. Roivant’s approach involved buying patents for unproven medications from bigger pharmaceutical firms and subsequently introducing them to the market. The business established a number of subsidiaries, such as Dermavant, Urovant, and Sinovant and Cytovant, which are situated in China.
In 2015, Ramaswamy tried to sell intepirdine as an Alzheimer’s disease medication by raising $360 million for Axovant Sciences, a Roivant affiliate. For $5 million, a negligible amount in the business, Axovant acquired the intepirdine patent from GlaxoSmithKline. When Ramaswamy was featured on the cover of Forbes in 2015, he hailed the drug as a “tremendous” prospect that may benefit millions of patients and promised that his company will be the “Berkshire Hathaway of drug research.”
The company’s worth plummeted after it revealed in September 2017 that intepirdine had failed its extensive clinical trial. Several institutional investors, including the California State Teachers’ Retirement System pension fund, were among the shareholders that suffered losses. Because he retained his interest through Roivant, Ramaswamy was shielded from a large portion of Axovant’s losses.
Sinovant was formed in 2017 by Roivant and the private equity division of the Chinese state-owned CITIC Group. In 2017, Ramaswamy and Masayoshi Son reached an agreement whereby SoftBank contributed $1.1 billion to Roivant. Roivant made $175 million in capital gains in 2019 when it sold Sumitomo Dainippon Pharma its interest in five subsidiaries (or “vants”), including Enzyvant.
Ramaswamy referred to himself as a “scientist” during his presidential campaign, saying, “I developed a number of medicines.” He was an entrepreneur and financier in the biotechnology sector. Ramaswamy became executive chairman of Roivant Sciences in January 2021 after resigning as CEO.
He left his position as chair of Roivant in February 2023 in order to concentrate on his presidential candidacy. With a 7.17% stake, Ramaswamy is still Roivant’s sixth-largest stakeholder. Roivant has never turned a profit while he was its manager.
Ramaswamy Net Worth
Forbes assessed Ramaswamy’s net worth at over $950 million in 2023, while his campaign advisor said he had over $1 billion.
